People: Transition Therapeutics Inc (TTH.TO)

TTH.TO on Toronto Stock Exchange

6.85CAD
24 Jul 2014
Price Change (% chg)

$-0.05 (-0.72%)
Prev Close
$6.90
Open
$6.85
Day's High
$6.85
Day's Low
$6.85
Volume
300
Avg. Vol
2,857
52-wk High
$9.25
52-wk Low
$4.04

Search Stocks

Pastrak, Aleksandra 

Brief Biography

Dr. Aleksandra Pastrak is Vice President - Clinical Development and Medical Officer of Transition Therapeutics Inc. Dr. Pastrak has been with Transition since 1999 and served as VP, Research since 2005 until she was appointed VP, Clinical Development in 2011. With her expertise in medicine and pharmacology, she has made an invaluable contribution to the development of our clinical programs for various therapeutic products. Dr. Pastrak holds an MD from the School of Medicine at the University of Belgrade and M.Sc. and Ph.D. degrees in Clinical Pharmacology from the University of Toronto.

Basic Compensation

Total Annual Compensation, CAD Long-Term Incentive Plans, CAD All Other, CAD Fiscal Year Total, CAD
300,937 -- 106,774 407,711

Options Compensation

  Quantity Market Value
Exercisable 62,553 294,692.00
Unexercisable 174,113 158,864.00
Exercised 742 6,010.00
Name Fiscal Year Total

Tony Cruz

706,308

Nicole Rusaw

316,054

Carl Damiani

319,775

Bruce Connop

287,182

Aleksandra Pastrak

407,711

Louis Alexopoulos

--
As Of 29 Jun 2013
Search Stocks